{"id":"W4411523842","doi":"10.2337/dc25-0942","title":"Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial","year":2025,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital","funders":"Division of Diabetes, Endocrinology, and Metabolic Diseases; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Evolocumab; Internal medicine; PCSK9; Diabetes mellitus; Unstable angina; Hazard ratio; Type 2 diabetes; Population; Clinical endpoint; Placebo; Type 1 diabetes; Randomized controlled trial; Myocardial infarction; Cardiology; Cholesterol; Endocrinology; Lipoprotein; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00317181,0.0006219607,0.001282081,0.0001654354,0.0001729826,0.0007900143,0.0003907648,0.0007418459,0.001277968],"category_scores_gemma":[0.004319952,0.0001580478,0.001434899,0.000192181,0.000399157,0.0004853156,0.0004951608,0.001242501,0.0001529658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002971344,"about_ca_system_score_gemma":0.0002910588,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003505159,"about_ca_topic_score_gemma":0.0007765153,"domain_scores_codex":[0.9989575,0.0006664805,0.00006034003,0.0001038298,0.0001218988,0.00008982084],"domain_scores_gemma":[0.9982602,0.0007686091,0.000531677,0.0001621245,0.00007940097,0.0001979632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7234932,0.002725629,0.08988612,0.002213686,0.01394314,0.0003054106,0.0002389004,0.002119331,0.002962949,0.00102917,0.005113197,0.1559694],"study_design_scores_gemma":[0.3897945,0.0899052,0.4781878,0.001505092,0.0214674,0.001033764,0.0003128174,0.004191278,0.002145347,0.002420181,0.008878572,0.0001581128],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839789,0.01254981,0.0002056748,0.0007752253,0.0001520346,0.000107968,0.0005703378,0.00001885017,0.00164113],"genre_scores_gemma":[0.9937207,0.003431883,0.0004927285,0.0005653407,0.0003869695,0.0001536133,0.0008029861,0.000006553928,0.0004392789],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00317181,"threshold_uncertainty_score":0.01677436,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008529580317728047,"score_gpt":0.2341755990822522,"score_spread":0.2256460187645242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}